Related Experiment Videos
Medication knowledge and self-management by people with type 2 diabetes
Trisha Dunning1, Elizabeth Manias
1Department of Endocrinology and Diabetes, St Vincent's Hospital, School of Nursing, The University of Melbourne, Victoria, Australia. trish.dunning@svhm.org.au
Summary
People with type 2 diabetes often have poor medication knowledge and self-management skills, leading to potential adverse events. Enhancing patient education on medication use and side effects is crucial for better diabetes management.
Area of Science:
- Endocrinology
- Pharmacology
- Patient Education
Background:
- Type 2 diabetes is a chronic condition requiring lifelong management.
- Effective self-management, including medication adherence, is vital for preventing complications.
- Polypharmacy is common in type 2 diabetes, increasing the complexity of self-care.
Purpose of the Study:
- To investigate the medication knowledge of individuals with type 2 diabetes.
- To assess the self-management practices related to medications in this population.
- To identify gaps in patient understanding and adherence to treatment regimens.
Main Methods:
- A cross-sectional study was conducted using in-depth interviews and participant observation.
- The study involved 30 participants with type 2 diabetes from a university teaching hospital's outpatient education center.
- Outcomes measured included the ability to recall medication details and perform self-management tasks.
Main Results:
- Participants commonly used multiple medications (mean 7 per person) and had existing diabetic complications.
- While most knew how to take medications, fewer received information on side effects (37%).
- Older adults faced challenges with medication packaging and administration, and some forgot doses or altered them due to cost.
Conclusions:
- Polypharmacy is prevalent among patients with type 2 diabetes.
- Medication knowledge and self-management skills were found to be insufficient.
- Inadequate knowledge and practices pose a risk for adverse events and necessitate improved patient education strategies.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...